PMC:7113449 / 4042-4470 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"77","span":{"begin":16,"end":24},"obj":"Species"},{"id":"78","span":{"begin":112,"end":140},"obj":"Species"},{"id":"79","span":{"begin":142,"end":145},"obj":"Species"},{"id":"80","span":{"begin":198,"end":201},"obj":"Species"},{"id":"81","span":{"begin":258,"end":261},"obj":"Species"},{"id":"82","span":{"begin":287,"end":302},"obj":"Chemical"},{"id":"87","span":{"begin":7,"end":15},"obj":"Disease"}],"attributes":[{"id":"A77","pred":"tao:has_database_id","subj":"77","obj":"Tax:9606"},{"id":"A78","pred":"tao:has_database_id","subj":"78","obj":"Tax:12721"},{"id":"A79","pred":"tao:has_database_id","subj":"79","obj":"Tax:12721"},{"id":"A80","pred":"tao:has_database_id","subj":"80","obj":"Tax:12721"},{"id":"A81","pred":"tao:has_database_id","subj":"81","obj":"Tax:12721"},{"id":"A82","pred":"tao:has_database_id","subj":"82","obj":"MESH:D016264"},{"id":"A87","pred":"tao:has_database_id","subj":"87","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Hence, COVID-19 patients would benefit from the administration of antiviral medications (nucleotide inhibitors, Human Immunodeficiency Virus (HIV) nucleoside reverse transcriptase inhibitor (NRTI), HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), HIV protease inhibitor (PI), dextran sulfate, and combination therapy, etc.) that will limit the spread of less virulent virus both within the body and in the population."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T5","span":{"begin":89,"end":99},"obj":"Body_part"},{"id":"T6","span":{"begin":142,"end":145},"obj":"Body_part"},{"id":"T7","span":{"begin":198,"end":201},"obj":"Body_part"},{"id":"T8","span":{"begin":258,"end":261},"obj":"Body_part"},{"id":"T9","span":{"begin":401,"end":405},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma82740"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma278683"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma278683"},{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma278683"},{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma256135"}],"text":"Hence, COVID-19 patients would benefit from the administration of antiviral medications (nucleotide inhibitors, Human Immunodeficiency Virus (HIV) nucleoside reverse transcriptase inhibitor (NRTI), HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), HIV protease inhibitor (PI), dextran sulfate, and combination therapy, etc.) that will limit the spread of less virulent virus both within the body and in the population."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T46","span":{"begin":7,"end":15},"obj":"Disease"},{"id":"T47","span":{"begin":118,"end":134},"obj":"Disease"}],"attributes":[{"id":"A46","pred":"mondo_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A47","pred":"mondo_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/MONDO_0021094"}],"text":"Hence, COVID-19 patients would benefit from the administration of antiviral medications (nucleotide inhibitors, Human Immunodeficiency Virus (HIV) nucleoside reverse transcriptase inhibitor (NRTI), HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), HIV protease inhibitor (PI), dextran sulfate, and combination therapy, etc.) that will limit the spread of less virulent virus both within the body and in the population."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T40","span":{"begin":112,"end":117},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T41","span":{"begin":135,"end":140},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T42","span":{"begin":379,"end":384},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"Hence, COVID-19 patients would benefit from the administration of antiviral medications (nucleotide inhibitors, Human Immunodeficiency Virus (HIV) nucleoside reverse transcriptase inhibitor (NRTI), HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), HIV protease inhibitor (PI), dextran sulfate, and combination therapy, etc.) that will limit the spread of less virulent virus both within the body and in the population."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T11","span":{"begin":66,"end":75},"obj":"Chemical"},{"id":"T12","span":{"begin":89,"end":99},"obj":"Chemical"},{"id":"T13","span":{"begin":100,"end":110},"obj":"Chemical"},{"id":"T14","span":{"begin":147,"end":157},"obj":"Chemical"},{"id":"T15","span":{"begin":158,"end":189},"obj":"Chemical"},{"id":"T17","span":{"begin":166,"end":189},"obj":"Chemical"},{"id":"T18","span":{"begin":180,"end":189},"obj":"Chemical"},{"id":"T19","span":{"begin":206,"end":216},"obj":"Chemical"},{"id":"T20","span":{"begin":217,"end":248},"obj":"Chemical"},{"id":"T22","span":{"begin":225,"end":248},"obj":"Chemical"},{"id":"T23","span":{"begin":239,"end":248},"obj":"Chemical"},{"id":"T24","span":{"begin":258,"end":280},"obj":"Chemical"},{"id":"T25","span":{"begin":262,"end":280},"obj":"Chemical"},{"id":"T27","span":{"begin":271,"end":280},"obj":"Chemical"},{"id":"T28","span":{"begin":282,"end":284},"obj":"Chemical"},{"id":"T33","span":{"begin":287,"end":302},"obj":"Chemical"},{"id":"T34","span":{"begin":287,"end":294},"obj":"Chemical"},{"id":"T35","span":{"begin":295,"end":302},"obj":"Chemical"}],"attributes":[{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_36976"},{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A14","pred":"chebi_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_33838"},{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_53756"},{"id":"A16","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_59897"},{"id":"A17","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_37416"},{"id":"A18","pred":"chebi_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A19","pred":"chebi_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/CHEBI_33838"},{"id":"A20","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_53756"},{"id":"A21","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_59897"},{"id":"A22","pred":"chebi_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/CHEBI_37416"},{"id":"A23","pred":"chebi_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A24","pred":"chebi_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_35660"},{"id":"A25","pred":"chebi_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/CHEBI_37670"},{"id":"A26","pred":"chebi_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/CHEBI_60258"},{"id":"A27","pred":"chebi_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A28","pred":"chebi_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_28874"},{"id":"A29","pred":"chebi_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_53806"},{"id":"A30","pred":"chebi_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_61484"},{"id":"A31","pred":"chebi_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_74790"},{"id":"A32","pred":"chebi_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_37670"},{"id":"A33","pred":"chebi_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/CHEBI_34674"},{"id":"A34","pred":"chebi_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/CHEBI_52071"},{"id":"A35","pred":"chebi_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/CHEBI_16189"}],"text":"Hence, COVID-19 patients would benefit from the administration of antiviral medications (nucleotide inhibitors, Human Immunodeficiency Virus (HIV) nucleoside reverse transcriptase inhibitor (NRTI), HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), HIV protease inhibitor (PI), dextran sulfate, and combination therapy, etc.) that will limit the spread of less virulent virus both within the body and in the population."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T12","span":{"begin":166,"end":179},"obj":"http://purl.obolibrary.org/obo/GO_0003968"},{"id":"T13","span":{"begin":166,"end":179},"obj":"http://purl.obolibrary.org/obo/GO_0003899"},{"id":"T14","span":{"begin":225,"end":238},"obj":"http://purl.obolibrary.org/obo/GO_0003968"},{"id":"T15","span":{"begin":225,"end":238},"obj":"http://purl.obolibrary.org/obo/GO_0003899"}],"text":"Hence, COVID-19 patients would benefit from the administration of antiviral medications (nucleotide inhibitors, Human Immunodeficiency Virus (HIV) nucleoside reverse transcriptase inhibitor (NRTI), HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), HIV protease inhibitor (PI), dextran sulfate, and combination therapy, etc.) that will limit the spread of less virulent virus both within the body and in the population."}

{"project":"LitCovid-sentences","denotations":[{"id":"T30","span":{"begin":0,"end":428},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Hence, COVID-19 patients would benefit from the administration of antiviral medications (nucleotide inhibitors, Human Immunodeficiency Virus (HIV) nucleoside reverse transcriptase inhibitor (NRTI), HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), HIV protease inhibitor (PI), dextran sulfate, and combination therapy, etc.) that will limit the spread of less virulent virus both within the body and in the population."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T20","span":{"begin":118,"end":134},"obj":"Phenotype"}],"attributes":[{"id":"A20","pred":"hp_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/HP_0002721"}],"text":"Hence, COVID-19 patients would benefit from the administration of antiviral medications (nucleotide inhibitors, Human Immunodeficiency Virus (HIV) nucleoside reverse transcriptase inhibitor (NRTI), HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), HIV protease inhibitor (PI), dextran sulfate, and combination therapy, etc.) that will limit the spread of less virulent virus both within the body and in the population."}